PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LABD vs. LABU
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


LABDLABU
YTD Return-40.60%6.71%
1Y Return-72.00%101.90%
3Y Return (Ann)-33.23%-50.94%
5Y Return (Ann)-55.99%-30.96%
Sharpe Ratio-0.961.68
Sortino Ratio-1.842.29
Omega Ratio0.801.27
Calmar Ratio-0.771.36
Martin Ratio-1.235.06
Ulcer Index62.23%26.41%
Daily Std Dev79.50%79.47%
Max Drawdown-99.97%-98.92%
Current Drawdown-99.97%-97.16%

Correlation

-0.50.00.51.0-1.0

The correlation between LABD and LABU is -1.00. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.

Performance

LABD vs. LABU - Performance Comparison

In the year-to-date period, LABD achieves a -40.60% return, which is significantly lower than LABU's 6.71% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
-20.00%
10.21%
LABD
LABU

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LABD vs. LABU - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is lower than LABU's 1.12% expense ratio.


LABU
Direxion Daily S&P Biotech Bull 3x Shares
Expense ratio chart for LABU: current value at 1.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.12%
Expense ratio chart for LABD: current value at 1.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.06%

Risk-Adjusted Performance

LABD vs. LABU - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LABD
Sharpe ratio
The chart of Sharpe ratio for LABD, currently valued at -0.96, compared to the broader market-2.000.002.004.006.00-0.96
Sortino ratio
The chart of Sortino ratio for LABD, currently valued at -1.84, compared to the broader market-2.000.002.004.006.008.0010.0012.00-1.84
Omega ratio
The chart of Omega ratio for LABD, currently valued at 0.80, compared to the broader market1.001.502.002.503.000.80
Calmar ratio
The chart of Calmar ratio for LABD, currently valued at -0.77, compared to the broader market0.005.0010.0015.00-0.77
Martin ratio
The chart of Martin ratio for LABD, currently valued at -1.23, compared to the broader market0.0020.0040.0060.0080.00100.00-1.23
LABU
Sharpe ratio
The chart of Sharpe ratio for LABU, currently valued at 1.68, compared to the broader market-2.000.002.004.006.001.68
Sortino ratio
The chart of Sortino ratio for LABU, currently valued at 2.29, compared to the broader market-2.000.002.004.006.008.0010.0012.002.29
Omega ratio
The chart of Omega ratio for LABU, currently valued at 1.27, compared to the broader market1.001.502.002.503.001.27
Calmar ratio
The chart of Calmar ratio for LABU, currently valued at 1.36, compared to the broader market0.005.0010.0015.001.36
Martin ratio
The chart of Martin ratio for LABU, currently valued at 5.06, compared to the broader market0.0020.0040.0060.0080.00100.005.06

LABD vs. LABU - Sharpe Ratio Comparison

The current LABD Sharpe Ratio is -0.96, which is lower than the LABU Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of LABD and LABU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JuneJulyAugustSeptemberOctoberNovember
-0.96
1.68
LABD
LABU

Dividends

LABD vs. LABU - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 5.34%, more than LABU's 0.40% yield.


TTM2023202220212020201920182017
LABD
Direxion Daily S&P Biotech Bear 3x Shares
5.34%6.14%0.53%0.00%3.96%1.75%0.80%0.00%
LABU
Direxion Daily S&P Biotech Bull 3x Shares
0.40%0.35%0.00%0.00%0.00%0.28%0.64%0.17%

Drawdowns

LABD vs. LABU - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.97%, roughly equal to the maximum LABU drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for LABD and LABU. For additional features, visit the drawdowns tool.


-100.00%-99.50%-99.00%-98.50%-98.00%-97.50%-97.00%-96.50%JuneJulyAugustSeptemberOctoberNovember
-99.97%
-97.16%
LABD
LABU

Volatility

LABD vs. LABU - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily S&P Biotech Bull 3x Shares (LABU) have volatilities of 17.00% and 17.63%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


14.00%16.00%18.00%20.00%22.00%24.00%JuneJulyAugustSeptemberOctoberNovember
17.00%
17.63%
LABD
LABU